Leptin effects on the regenerative capacity of human periodontal cells by Nokhbehsaim, Marjan et al.
Research Article
Leptin Effects on the Regenerative Capacity of
Human Periodontal Cells
Marjan Nokhbehsaim,1,2 Sema Keser,2 Andressa Vilas Boas Nogueira,2,3
Andreas Jäger,2,4 Søren Jepsen,2,5 Joni Augusto Cirelli,3 Christoph Bourauel,2,6
Sigrun Eick,7 and James Deschner1,2
1 Experimental Dento-Maxillo-Facial Medicine, University of Bonn, 53111 Bonn, Germany
2 Clinical Research Unit 208, University of Bonn, 53111 Bonn, Germany
3Department of Diagnosis and Surgery, School of Dentistry, UNESP, 14801-903 Araraquara, SP, Brazil
4Department of Orthodontics, University of Bonn, 53111 Bonn, Germany
5Department of Periodontology, Operative and Preventive Dentistry, University of Bonn, 53111 Bonn, Germany
6Oral Technology, Center of Dento-Maxillo-Facial Medicine, University of Bonn, 53111 Bonn, Germany
7Department of Periodontology, Laboratory of Oral Microbiology, University of Bern, 3010 Bern, Switzerland
Correspondence should be addressed to James Deschner; james.deschner@uni-bonn.de
Received 24 February 2014; Revised 26 June 2014; Accepted 4 July 2014; Published 22 July 2014
Academic Editor: Daniela Jezova
Copyright © 2014 Marjan Nokhbehsaim et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Obesity is increasing throughout the globe and characterized by excess adipose tissue, which represents a complex endocrine
organ. Adipose tissue secrets bioactivemolecules called adipokines, which act at endocrine, paracrine, and autocrine levels. Obesity
has recently been shown to be associated with periodontitis, a disease characterized by the irreversible destruction of the tooth-
supporting tissues, that is, periodontium, and also with compromised periodontal healing. Although the underlying mechanisms
for these associations are not clear yet, increased levels of proinflammatory adipokines, such as leptin, as found in obese individuals,
might be a critical pathomechanistic link.Theobjective of this studywas to examine the impact of leptin on the regenerative capacity
of human periodontal ligament (PDL) cells and also to study the local leptin production by these cells. Leptin caused a significant
downregulation of growth (TGF𝛽1, and VEGFA) and transcription (RUNX2) factors as well as matrix molecules (collagen, and
periostin) and inhibited SMAD signaling under regenerative conditions. Moreover, the local expression of leptin and its full-length
receptor was significantly downregulated by inflammatory, microbial, and biomechanical signals. This study demonstrates that
the hormone leptin negatively interferes with the regenerative capacity of PDL cells, suggesting leptin as a pathomechanistic link
between obesity and compromised periodontal healing.
1. Introduction
Theprevalence of overweight and obesity has been increasing
throughout the globe over the past decades [1, 2]. According
to a recent survey conducted in Germany from 2008 through
2011, 67.1% of men and 53.0% of women are overweight, and
23.3% of men and 23.9% of women are obese. Moreover, the
prevalence of obesity has risen substantially in this popula-
tion [3]. Since obesity is an important risk factor for many
chronic diseases and conditions, such as type 2 diabetesmelli-
tus, dyslipidemia, hypertension, cardiovascular diseases, and
cancer, massive healthcare costs associated with the obesity
epidemic have become a heavy financial burden for the econ-
omy and emerged as some of the most pressing global issues
[1, 4–6].
Obesity is characterized by excess adipose tissue, inwhich
adipocytes are increased in number and volume. Adipose
tissue is considered a complex endocrine and highly active
metabolic organ, which synthesizes and secretes a variety
of bioactive molecules called adipokines [7–10]. These mol-
ecules act at both the systemic (endocrine) and the local
(autocrine/paracrine) levels. Obesity causes an increase in
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the synthesis of proinflammatory adipokines, such as leptin,
and a decrease in the production of anti-inflammatory adi-
pokines, which results in the development of a chronic, low-
grade inflammatory state [7–10].
Leptin is an adipose-derived hormone secreted in propor-
tion to size and number of adipocytes.Therefore, plasma lep-
tin levels are increased in obesity and decreased after weight
loss [11]. Although leptin is mainly synthesized by adipose
tissue, this adipokine is also produced at low levels in other
tissues. Leptin inhibits appetite, stimulates energy expendi-
ture, and modulates lipid and bone metabolism, coagulation,
hematopoiesis, function of pancreatic beta-cells, and insulin
sensitivity [8, 12]. Moreover, leptin regulates the immune
system and inflammatory response, with mainly proinflam-
matory actions [8, 12–15].
Leptin mediates its effects by binding to the full-length
leptin receptor (LEPR). In addition to brain, LEPR is also
expressed in a wide range of peripheral tissues. Upon binding
of leptin to its receptor, a number of intracellular pathways
and transcription factors are activated [12–16].
Recent meta-analyses have revealed that obesity is asso-
ciated with periodontitis, a chronic disease characterized by
the irreversible destruction of the tooth-supporting tissues,
that is, periodontium [17, 18]. The periodontium consists of
the gingiva, periodontal ligament (PDL), root cementum, and
alveolar bone. Pathogenic bacteria, such as Fusobacterium
nucleatum, Porphyromonas gingivalis, and Treponema denti-
cola in the subgingival dental plaque, are essential for the
initiation and progression of periodontitis [19, 20]. How-
ever, cofactors, such as smoking, genetic predisposition, or
occlusal loading, can also contribute to the development
of periodontitis [21]. The pathogenic bacteria provoke an
inflammatory host response, which involves inflammatory
molecules, such as interleukin (IL)-1𝛽, in the periodontal
tissues. If the inflammatory process is exaggerated and sus-
tained,matrix degradation and bone resorption, formation of
periodontal pockets, and even tooth loss can occur [21, 22].
Periodontitis can be successfully treated. By reducing or
eliminating the pathogenic microorganisms in the periodon-
tal pockets, periodontal therapy seeks to arrest inflammation
and tissue destruction [23]. Regeneration of lost periodontal
structures can be stimulated by the application of bioactive
molecules, such as enamel matrix derivative (EMD), during
periodontal surgery [24–26]. EMD induces the production
of several growth factors, such as transforming growth factor
(TGF) 𝛽1 and vascular endothelial growth factor (VEGF) A,
matrix molecules, such as collagen type I (COL1) and per-
iostin (POSTN), and osteogenesis-related factors, such as
runt-related transcription factor (RUNX) 2, and accelerates
in vitro wound healing [27, 28]. The regeneration-promo-
tive effects of EMD are mediated, at least in part, by bone
morphogenetic protein (BMP) and TGF𝛽, which trigger
SMAD (sma- and mad-related protein) and non-SMAD sig-
naling cascades [29–33]. A number of studies have shown
that microbial, inflammatory, and biomechanical signals can
interfere with the beneficial effects of EMD on periodontal
cells, emphasizing the critical role of the cell environment for
optimal periodontal regeneration [34–36].
Interestingly, obesity also negatively affects the response
to periodontal therapy [37, 38]. The underlying mechanisms
are not clear yet and increased serum levels of proinflam-
matory adipokines, as found in obese individuals, might be
a critical pathomechanistic link in the association between
obesity and compromised periodontal healing.Therefore, the
objective of this in vitro study was to examine the impact
of the proinflammatory hormone leptin on the regenerative
capacity of PDL cells and to study the local production of
leptin and its full-length receptor by these cells.
2. Materials and Methods
2.1. Culture and Treatment of Cells. Human PDL cells were
derived from 21 periodontally healthy donors (mean age:
16.0 ± 1.4 years, min-max: 10–42 years; gender: 6 male/15
female; all normal weight), who had to undergo tooth extrac-
tion for orthodontic reasons. Written informed consent and
approval of the Ethics Committee of the University of Bonn
were obtained. Cells were derived from PDL explants as
described elsewhere [39, 40]. Briefly, PDL tissue explants
were dissected from the middle third of the root surface with
a sharp scalpel then washed with phosphate-buffered saline
(PBS, Sigma-Aldrich, Munich, Germany), minced into small
pieces, and, finally, cultured in Dulbecco’s modified essential
medium (DMEM, Invitrogen, Karlsruhe, Germany) supple-
mented with 10% fetal bovine serum (FBS, Invitrogen), 100
units penicillin, and 100 𝜇g/mL streptomycin (Invitrogen) at
37∘C in a humidified atmosphere of 5% CO
2
for 2 to 4 weeks.
Afterwards, cells were transferred into flasks for continued
growth and phenotyped with the use of osteogenic markers
[40]. Cells between 3rd and 5th passage were seeded (5,000
cells/cm2) on culture plates and grown to 80% confluence.
One day prior to the experiments, the FBS concentration was
reduced to 1%.Mediumwas changed every other day. In order
to investigate the effects of leptin, various concentrations of
this adipokine (1, 3, and 10 ng/mL; R&D Systems, Minneapo-
lis, MN, USA) were added to cells. The leptin concentrations
used in the present study are in the physiological range and
have been measured in GCF from obese individuals [41]. To
mimic regenerative conditions in vitro, cells were incubated
with EMD (Emdogain, Straumann, Freiburg, Germany) at a
concentration of 100𝜇g/mL. In the present study, the com-
mercially available product Emdogain, which consists of
enamel matrix derivative and the vehicle propylene glycol
alginate, was used. Our previous experiments revealed that
the effects of Emdogain on the cell functions examined in
the present study were identical to those of enamel matrix
derivative without the vehicle (unpublished data). In order to
simulate an inflammatory environment, cells were incubated
with IL-1𝛽 (1 ng/mL; Calbiochem, San Diego, CA, USA). An
infectious environment was mimicked by stimulating cells
with the inactivated oral periodontopathogens F. nucleatum
ATCC 25586, P. gingivalis ATCC 33277, or T. denticola
ATCC 35405 (optical density: 0.1). Bacteria were suspended
in PBS (OD
660
nm = 1, equivalent to 1.2 × 109 bacterial
cells/mL) and subjected two times to ultrasonication (160W
for 15min) resulting in a complete killing. Biomechanical
loading conditionswere accomplished by application of cyclic
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tensile strain (CTS, 20%) at a rate of 0.05Hz to cells by using a
strain device (CESTRA) developed at the University of Bonn.
The strain regimen and the aforementioned concentrations
had also been used in our previous experiments and ensured
that data were comparable [42–47]. In order to unravel the
intracellular mechanisms exploited by leptin to modulate
the actions of EMD, cells were preincubated with a specific
inhibitor against the NF𝜅B signaling pathway (pyrrolidine
dithiocarbamate, PDTC; 10 𝜇M; Calbiochem) 1 h prior to
experiments.
2.2. In Vitro Wound Healing. In order to study the effects of
leptin on wound fill, an established in vitro wound healing
model was used, as described in our previous experiments
[44, 45, 47]. Briefly, cells were grown until confluence and
3mm wide wounds, that is, cell-free areas, were created in a
standardized manner in the cell monolayers. The wounded
monolayers were treated with leptin (3 ng/mL) in the pres-
ence and absence of EMD for 4 d. Every day, the wounds
were documented by inverse microscopy (Axiovert 25 C,
5x objective, Carl Zeiss, Oberkochen, Germany) and digital
photography (Kodak DC 290, Kodak, Stuttgart, Germany).
Afterwards, measurement and analysis of the wound widths
were performed with special software (Alpha DigiDoc 1000,
Alpha Innotech, San Leandro, CA, USA).
2.3. Real-Time PCR. RNA was extracted by using an RNA
extraction kit (Qiagen, Hilden, Germany), and a total of 1 𝜇g
of RNA was reverse transcribed using iScript Select cDNA
Synthesis Kit (Bio-Rad Laboratories, Munich, Germany) at
42∘C for 90min followed by 85∘C for 5min. Expression
of TGF𝛽1, VEGFA, COL1, POSTN, RUNX2, Ki67, TGF𝛽
receptors (TGF𝛽R1, TGF𝛽R2), BMP receptors (BMPR1A,
BMPR1B, and BMPR2), leptin, full-length LEPR, IL-6, tumor
necrosis factor (TNF) 𝛼, cyclooxygenase (COX) 2, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
detected by real-time PCR using the iCycler iQ detection
system (Bio-Rad Laboratories), SYBR Green (Bio-Rad Lab-
oratories), and specific primers (QuantiTect Primer Assay,
Qiagen). One 𝜇L of cDNA was amplified as a template in
a 25 𝜇L reaction mixture containing 12.5 𝜇L 2x QuantiFast
SYBR Green PCR Master Mix (Qiagen), 2.5 𝜇L of primers
(0.5 𝜇M each), and 9 𝜇L deionized water. The mixture was
heated initially at 95∘C for 5min and then followed by
40 cycles with denaturation at 95∘C for 10 s and combined
annealing/extension at 60∘C for 30 s. GAPDHwas used as an
endogenous control. The data were analyzed by the compar-
ative threshold cycle method.
2.4. ELISA. Protein levels of TGF𝛽1, VEGFA, and leptin
released from the cells into the medium and LEPR protein in
cell lysatesweremeasured by commercially available enzyme-
linked immunosorbent assay (ELISA) kits (R&D Systems)
according to themanufacturer’s instructions.The absorbance
was analyzed by using a microplate reader (PowerWave x,
BioTek Instruments, Winooski, VT, USA) at 450 nm. Data
were normalized by cell number determined with an auto-
matic cell counter (Moelab, Hilden, Germany).
2.5. Immunofluorescence. Cells were fixed with 4% para-
formaldehyde in PBS pH 7.4 for 10min, washed with PBS
(Sigma-Aldrich, Munich, Germany), and treated with 0.1%
Triton X-100 (Sigma-Aldrich) for 5min. Afterwards, cells
were washed again and blocked with nonfat dry milk (Bio-
Rad Laboratories) for 1 h. After washing, cells were incubated
with primary rabbit anti-SMAD1/5/8 (1 : 200; Santa Cruz
Biotechnology, Santa Cruz, CA, Germany) or anti-NF𝜅B
p65 (1 : 400; Cell Signalling Technology, Danvers, MA, USA)
antibodies for 90min and with CY3-conjugated goat anti-
rabbit IgG (1 : 2,000; Abcam, Cambridge, MA, USA) for
45min. Cells were observed under a 20x objective using an
Axioplan 2 imagingmicroscope (Carl Zeiss).The imageswere
captured with a PVCAM camera and the VisiView capturing
software (Visitron Systems, Puchheim, Germany).
2.6. Statistical Analysis. All experiments were performed in
triplicate and repeated at least twice. Mean values and stand-
ard errors of the mean (SEM) were calculated. Parametric
(ANOVA followed by Dunnett’s or Tukey’s tests) and non-
parametric (Mann-Whitney 𝑈) tests were applied for statis-
tical analysis by using the IBM SPSS Statistics 22 software
(IBM Corporation, Armonk, NY, USA). Differences between
groups were considered significant at 𝑃 < 0.05.
3. Results
3.1. Inhibition of EMD Effects by Leptin. EMD caused a sig-
nificant increase in the TGF𝛽1, VEGFA, COL1, and POSTN
expressions and tended to upregulate RUNX2 at 1 d, as
shown in Figure 1(a). Interestingly, when EMD-treated cells
were concomitantly exposed to leptin, the EMD-induced
TGF𝛽1, VEGFA, COL1, POSTN, and RUNX2 expressions
were significantly reduced at this time point (Figure 1(a)). A
significant upregulation of TGF𝛽1, VEGFA, COL1, POSTN,
and RUNX2 expressions was also found at 3 d (Figure 1(b)).
At this time point, leptin inhibited significantly the EMD-
induced VEGFA and COL1 expressions and also showed
a tendency to decrease the EMD-induced TGF𝛽1, POSTN,
and RUNX2 expressions (Figure 1(b)). As depicted in Figures
1(c)–1(e), the inhibitory effects of leptin on EMDactions were
observed for different concentrations of this adipokine and
also at protein level, as evidenced by reduced TGF𝛽1 and
VEGFAprotein levels in the presence of leptin. In the absence
of EMD, leptin only inhibited significantly the VEGFA pro-
duction at 1 d (Figures 1(a) and 1(e)) and the COL1 expression
at 1 and 3 d (Figures 1(a) and 1(b)).
In an in vitro wound healing model, the impact of leptin
on wound closure in the presence and absence of EMD was
studied. In the presence of EMD, leptin increased signifi-
cantly the wound closure at 1, 2, 3, and 4 d, as compared
to leptin-untreated cell cultures, as shown in Figure 2(a).
In the absence of EMD, leptin tended to stimulate the
wound closure at 1, 2, and 3 d and increased significantly the
wound closure at 4 d (Figure 2(a)). Since the wound closure
results from proliferation and migration in this model, we
further studied the influence of leptin on proliferation. As
expected, EMD caused an increase in Ki67, a marker of
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Figure 1: Effect of EMD and/or leptin (3 ng/mL) on TGF𝛽1, VEGFA, COL1, POSTN, and RUNX2 mRNA at 1 d (a) and 3 d (b). Untreated
cells served as control. Mean ± SEM (𝑛 = 18); ∗significant (𝑃 < 0.05) difference between groups. Effect of various concentrations (0, 1, 3, and
10 ng/mL) of leptin on TGF𝛽1 and VEGFA mRNA in EMD-treated cells at 1 d (c). Mean ± SEM (𝑛 = 9); ∗significant (𝑃 < 0.05) difference
between groups. Effect of EMD and/or leptin (3 ng/mL) on protein levels of TGF𝛽1 (d) and VEGFA (e) released from cells into the medium
at 1 d. Untreated cells served as control. Mean ± SEM (𝑛 = 18); ∗significant (𝑃 < 0.05) difference between groups.
proliferation, at 1 and 3 d (Figure 2(b)). However, the EMD-
upregulated Ki67 expression was not significantly affected by
leptin at both time points. Leptin had also no impact on the
cell numbers in the presence or absence of EMD (data not
shown).
3.2. Effect of Leptin on Intracellular Signaling. EMD induced
a nuclear translocation of SMAD1/5/8, which was most
pronounced at 60min. However, in the presence of leptin,
the EMD-stimulated SMAD1/5/8 nuclear translocation was
almost completely blocked, as shown in Figures 3(a)–3(f).
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Figure 2: Effect of leptin (3 ng/mL) on wound closure in the presence and absence of EMD (a). The wound closure, that is, the percentage of
fill of the initially cell free zones created by wounding, was analyzed over 4 d. Mean ± SEM (𝑛 = 12); ∗significantly (𝑃 < 0.05) different from
leptin-untreated cells. Effect of EMD and/or leptin (3 ng/mL) on Ki67 mRNA at 1 d and 3 d (b). Untreated cells served as control. Mean ±
SEM (𝑛 = 18); ∗significant (𝑃 < 0.05) difference between groups.
Next, we sought to examine a possible involvement of
NF𝜅B in the inhibitory actions of leptin on EMD. When
cells were incubated with a specific inhibitor of NF𝜅B sig-
naling, the leptin-induced inhibition of the EMD-stimulated
expression of TGF𝛽1, VEGFA, and COL1 was abrogated by
95%, 29%, and 100%, respectively, at 1 d, as analyzed by real-
time PCR. Interestingly, leptin did not cause a remarkable
NF𝜅B nuclear translocation over 90min, as evidenced by
immunofluorescence (Figures 4(a)–4(d)).
3.3. Impact of Leptin on Receptors for TGF𝛽 and BMP. Since
EMD contains TGF𝛽- and BMP-like activity and, therefore,
exploits receptors for these growth and differentiation factors,
we next studied the effects of leptin on TGF𝛽R1, TGF𝛽R2,
BMPR1A, BMPR1B, and BMPR2. Although there were no
significant effects on these receptors at 1 d, leptin reduced
significantly the TGF𝛽R1, TGF𝛽R2, BMPR1A, and BMPR2
expressions at 3 d (Figure 4(e)).
3.4. Regulation of Leptin and Its Receptor in PDL Cells. Next,
we sought to examine if and underwhat conditions leptin and
LEPR are produced in PDL cells. Leptin was constitutively
expressed and this constitutive expression was significantly
downregulated by IL-1𝛽, CTS, F. nucleatum, P. gingivalis, and
T. denticola at 1 d (data not shown) and 3 d (Figure 5(a)).
The inhibitory effects were also found at protein level, as
evidenced by the reduced protein levels of leptin released
from cells exposed toCTS or F. nucleatum at 3 d (Figure 5(b)).
Similar results were also observed for LEPR. Although IL-
1𝛽 had no significant effect on the receptor expression, CTS,
F. nucleatum, P. gingivalis, and T. denticola inhibited signif-
icantly LEPR at both time points (Figure 5(c)). In addition,
CTS, F. nucleatum, P. gingivalis, and T. denticola reduced
significantly the cellular LEPR protein level as measured in
cell lysates at 1 d (Figures 5(d) and 5(e)). Since our experi-
ments revealed that leptin is also produced by PDL cells, we
wondered how leptinwould affect its own expression and that
of its receptor. As shown in Figure 5(f), leptin had no effect
on its own expression, but caused a significant reduction of
LEPR expression at 3 d.
3.5. Effects of Leptin on Inflammatory Mediators. In order
to clarify whether leptin exerts proinflammatory effects by
upregulation of inflammatory mediators, we also studied the
expression of IL-6, TNF𝛼, and COX2 in PDL cells. Whereas
leptin had no impact on all these molecules at 1 d and on IL-6
at 3 d, leptin caused a slight but significant TNF𝛼 upregula-
tion and COX2 downregulation at 3 d (Figure 5(g)).
4. Discussion
The present study provides original evidence that the hor-
mone leptin, whose plasma and gingival crevicular fluid
(GCF) levels are increased in obese individuals, negatively
interfereswith the regenerative capacity of PDL cells (Figure 6)
[11, 41]. A number of PDL cell functions critical for perio-
dontal regeneration were significantly compromised in the
presence of this adipokine. Our observation is in line with
a previous study, in which visfatin, another proinflammatory
adipokine, has also been shown to abrogate the regeneration-
promotive effects of EMD on periodontal cells [47]. These
studies underline the detrimental role of proinflammatory
adipokines in periodontal healing and strongly suggest such
adipokines as a pathomechanistic link between obesity and
compromised periodontal healing. Future studies should also
focus on the effects of leptin on other periodontal cells, such
6 International Journal of Endocrinology
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Figure 3: Effect of EMD on the nuclear translocation of SMAD1/5/8 in the presence and absence of leptin (3 ng/mL), as determined by
immunofluorescence ((a)–(f)). Experiments were performed in triplicate and repeated twice. Untreated cells served as control. Images from
one representative donor are shown.
as gingival cells aswell as osteo- and cementoblasts, since they
are also critical to periodontal healing.
Our experiments revealed that leptin counteracted the
stimulatory effects of EMD on the synthesis of growth and
transcription factors aswell as extracellularmatrixmolecules,
which are strongly involved in periodontal regeneration.
VEGFA promotes wound healing by its stimulatory effects
on vascular permeability and recruitment of circulating neu-
trophils and monocytes to the site of injury. This growth fac-
tor enhances survival, proliferation, migration, and invasion
of endothelial cells, thereby contributing to angiogenesis. In
addition,VEGFA stimulates pericytes to coat and stabilize the
vasculature [48–50]. Although leptin upregulatesVEGFA in a
number of cells, the VEGFA expression and release fromPDL
cells were reduced by leptin in our experiments [51, 52]. Inter-
estingly, in human gingival biopsies, the leptin concentration
decreases as the probing pocket depth increases. Moreover,
the decrease in leptin is associatedwith an increase inVEGFA
[53]. This negative correlation between leptin and VEGFA in
human gingiva supports our finding and may suggest that
leptin has no proangiogenic effects on periodontal tissues.
However, further experiments are needed to clarify this point.
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Figure 4: Effect of leptin (3 ng/mL) on the nuclear translocation of NF𝜅B p65, as examined by immunofluorescence ((a)–(d)). Experiments
were performed in triplicate and repeated twice. Untreated cells served as control. Images from one representative donor are shown. Effect
of leptin (3 ng/mL) on TGF𝛽R1, TGF𝛽R2, BMPR1A, BMPR1B, and BMPR2 mRNA at 3 d (e). Untreated cells served as control. Mean ± SEM
(𝑛 = 18); ∗significantly (𝑃 < 0.05) different from control.
TGF𝛽, another important growth factor, comprises three
isoforms and also promotes wound healing by its stimulatory
effects on the migration, chemotaxis, and proliferation of
monocytes/macrophages, fibroblasts, and endothelial cells,
keratinocyte migration and reepithelialization, the synthesis
of extracellular matrix molecules, and differentiation of stem
cells [54–56]. For periodontal homeostasis and regeneration,
matrix molecules, such as COL1 and POSTN, are also essen-
tial. COL1 is responsible for the mechanical characteristics
of the periodontal connective tissues and provides tensile
strength. POSTN promotes formation of high stiffness colla-
gen through effective collagen cross-linking and also interacts
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Figure 5: Effect of interleukin (IL)-1𝛽, cyclic tensile strain (CTS), F. nucleatum (Fn), P. gingivalis (Pg), and T. denticola (Td) on leptin mRNA
in PDL cells at 3 d (a). Untreated cells served as control. Mean ± SEM (𝑛 = 9); ∗significantly (𝑃 < 0.05) different from control. Effects of CTS
and Fn on the protein level of leptin released from cells into the medium at 3 d (b). Untreated cells served as control. Mean ± SEM (𝑛 = 18);
∗significant (𝑃 < 0.05) difference between groups. Effects of IL-1𝛽, CTS, Fn, Pg, and Td on leptin receptor (LEPR) mRNA in PDL cells at
1 d and 3 d (c). Untreated cells served as control. Mean ± SEM (𝑛 = 9); ∗significantly (𝑃 < 0.05) different from control. Effects of CTS (d)
and Fn, Pg, and Td (e) on LEPR protein in lysates from PDL cells at 1 d. Untreated cells served as control. Mean ± SEM (𝑛 = 18); ∗significant
(𝑃 < 0.05) difference between groups. Effect of leptin (3 ng/mL) on its own mRNA and that of its receptor in PDL cells at 1 d and 3 d (f).
Untreated cells served as control. Mean ± SEM (𝑛 = 18); ∗significantly (𝑃 < 0.05) different from control. Effect of leptin (3 ng/mL) on IL-6,
tumor necrosis factor (TNF) 𝛼, and cyclooxygenase (COX) 2 mRNA in PDL cells at 3 d (g). Untreated cells served as control. Mean ± SEM
(𝑛 = 18); ∗significantly (𝑃 < 0.05) different from control.
with other extracellular matrix molecules. Moreover, POSTN
aids in dispersing mechanical forces applied to the PDL
and also plays a role in osteoblast adhesion, differentiation,
and survival [57–59]. PDL cells can also undergo osteogenic
differentiation, and several studies have demonstrated that
EMD stimulates the expression of osteogenesis-associated
factors, such as RUNX2, in PDL cells [27]. RUNX2 is a critical
transcription factor in osteoblast commitment and differen-
tiation and, thereby, bone formation [60]. Leptin abrogated
the stimulatory actions of EMD on the aforementioned
growth and transcription factors as well as matrix molecules,
suggesting that leptin may interfere with the EMD-induced
effects on both periodontal soft and hard tissue regeneration.
Interestingly, leptin did not compromise the in vitro
wound healing, which is in clear contrast to our previous
findings in PDL cells, which were exposed to visfatin [47].
Leptin enhanced the wound closure, especially in the pres-
ence of EMD. Since the in vitro wound healing may be
affected by proliferation, we also studied the effect of leptin on
Ki67, a marker of cell proliferation. As expected, EMD caused
a significant Ki67 upregulation. However, leptin did not fur-
ther enhance the EMD-induced Ki67 expression, suggesting
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Figure 6: Hypothetical scheme illustrating the possible involvement of leptin in the relationship of obesity with periodontal destruction and
compromised periodontal healing. The hormone leptin, whose plasma and gingival crevicular fluid levels are increased in obese individuals,
inhibits the production of growth factors and extracellular matrix molecules by PDL cells under normal (absence of EMD) and regenerative
(presence of EMD) conditions, which in turn could favor periodontal destruction and compromised periodontal healing, respectively.
that the beneficial effects of leptin on wound healing are not
accomplished by stimulating PDL cell proliferation. Further
studies should clarify if and how leptin impacts migration,
which also determines the wound fill rate in this healing
assay.
To the best of our knowledge, the present study shows
for the first time that leptin inhibits SMAD signaling in
EMD-treated PDL cells. As already shown in our previous
studies, EMD, which has TGF𝛽- and BMP-like activity,
triggers the SMAD signaling pathway [44, 47]. Interest-
ingly, leptin abrogated the stimulatory effect of EMD on the
nuclear translocation of SMADs, similarly to visfatin. There-
fore, the SMAD signaling pathway may be a critical target
for the inhibitory actions of proinflammatory adipokines
in PDL cells. When cells were preincubated with a specific
inhibitor of NF𝜅B signaling, the leptin-induced inhibition of
the EMD-stimulated upregulation of TGF𝛽1, VEGFA, and
COL1 was abrogated by 95%, 29%, and 100%, respectively,
after 1 d. These results indicate that the NF𝜅B pathway is
also involved in the counteracting effects of leptin on EMD.
However, as evidenced by immunofluorescence, leptin did
not cause a remarkable NF𝜅B nuclear translocation within
90min, suggesting that NF𝜅B transactivation maybe be a
later event and not caused directly by leptin. Further studies
are needed to clarify howNF𝜅B interferes with SMAD signal-
ing and whether additional intracellular signaling pathways
are exploited by leptin for its inhibitory actions.
Our previous studies have shown that inflammatory and
biomechanical signals can impact BMP and TGF𝛽 receptors
[44, 45, 47, 61]. Since EMD contains BMP- and TGF𝛽-like
activity, we also studied the influence of leptin on these
receptors. Interestingly, leptin caused a downregulation of
the BMP and TGF𝛽 receptors by 20–30%, indicating that
leptin may regulate actions of EMD also at receptor level.
Since obesity is characterized by leptin resistance, further
studies should examine if the effects of leptin, as found in
the present study, can be confirmed in PDL cells from obese
individuals. Currently, we are studying the effects of obesity
on periodontal regeneration in an established fenestration-
type defectmodel in rats fedwith normal or high-fat diet.This
in-vivo study will help verify our in-vitro data and provide
further insight into the role of obesity in periodontal homeo-
stasis and healing.
A number of studies have shown that periodontitis results
in elevated serum levels of leptin and that periodontal therapy
can reduce serum leptin levels in periodontally-diseased
patients [41, 62–65]. By contrast, leptin levels are decreased
in GCF and gingival tissues in periodontitis patients, as
compared to periodontally healthy individuals [53, 62, 66,
67]. In addition, smoking and biomechanical forces also lead
to reduced leptin levels in GCF [68, 69].These studies suggest
that periodontitis, smoking, and biomechanical forces impact
the local leptin synthesis in periodontium.However, only few
studies have focused on the local production of leptin and
its full-length receptor in periodontal tissues. These studies
have demonstrated that leptin and its receptor are synthesized
in PDL, gingival, and alveolar bone cells [70, 71]. Our study
confirms that both leptin and its receptor are constitutively
expressed in PDL cells. The leptin release from PDL cells
might be lower than that from adipocytes [72, 73]. However,
a comparison is difficult, because even the leptin secretion
from adipocytes depends on a number of parameters, such
as gender, subcutaneous or omental origin, and genotype
[74, 75].
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Our findings provide original evidence that inflamma-
tory, microbial, and biomechanical signals cause a significant
downregulation of leptin and its receptor. This observation
is in accordance with the aforementioned clinical studies,
which found decreased leptin levels in GCF from periodon-
tally diseased or biomechanically loaded sites [62, 66, 67].
Although only PDL cells were used in our experiments,
it can be speculated that the increased serum leptin levels
observed in periodontitis do not result from an enhanced
local production of leptin in the periodontium. Interestingly,
our experiments did not reveal any autostimulation of leptin
or its receptor. Further studies should clarify the regulation
of leptin and its receptor in other periodontal cells and their
contribution to the altered leptin levels in periodontitis.
It has been reported that leptin enhances the TNF𝛼
production in LPS-stimulated macrophages, confirming the
proinflammatory characteristics of leptin [76]. Although lep-
tin also increased the TNF𝛼 expression in our experiments,
IL-6 was not regulated by leptin. Moreover, the expression
level of COX2 was slightly, but significantly, downregulated
by this adipokine. Further studies are needed to prove the
proinflammatory nature of leptin in the PDL.
As in our previous experiments, IL-1𝛽 was used to sim-
ulate inflammatory conditions in vitro, because this proin-
flammatory cytokine is increased in GCF and gingival tissues
at inflamed sites [42, 44, 46, 77–79]. In order to mimic
microbial conditions in vitro, PDL cells were treated with
a suspension of F. nucleatum, P. gingivalis, and T. denticola.
P. gingivalis and T. denticola are gram-negative anaerobic
bacteria and strongly linked to periodontitis [80–82].F. nucle-
atum, which is also a gram-negative microorganism, is
associated with both gingivitis and periodontitis and acts as
a bridge bacterium between early and late colonizers during
plaque development [83–85]. Since periodontitis is caused
by a complex bacterial biofilm, further studies should clarify
whether leptin and its receptor are also regulated by other
microorganisms, which are associatedwith periodontitis.The
suspensions were subjected to intensive ultrasonication and
contained disrupted cell wall particles with a high amount
of LPS. However, additional microbial components may have
been present in the suspensions. As in our previous studies,
cells were subjected to tensile forces [43, 45, 61, 86]. However,
duringmastication, dental habits, and orthodontic treatment,
the periodontium is subject to complex forces. Whether
compressive, hydrostatic, and shear forces as well as their
combinations exert similar effects on the production of leptin
and its receptor has yet to be determined.
Taken together, our study shows for the first time that
inflammatory, microbial, and biomechanical signals can
inhibit the expression of leptin and its receptor in PDL
cells, which may explain, at least in part, the reduced GCF
leptin levels found in periodontitis and orthodontic patients.
Furthermore, our experiments provide original evidence
that the hormone leptin, whose plasma and GCF levels are
increased in obese individuals, negatively interferes with the
regenerative capacity of PDL cells, suggesting leptin as a
pathomechanistic link between obesity and compromised
periodontal healing.
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